|
|
|
|
Health Highlights: March 12, 2010
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: A settlement has been reached in a lawsuit by thousands of Ground Zero rescue and cleanup workers against New York City.The settlement of up...
|
|
|
URS settles with Minn. for $5M in bridge collapse
Contractor URS Corp.and the state of Minnesota reached a $5 million settlement Friday in the state's lawsuit over the 2007 downtown Minneapolis bridge collapse that killed 13 people and injured 145 others. URS had a long-standing contract with the...
|
|
|
Pharmaceutical Firm to Pay $42.5M for False Claims about Pain-Relief Drug
American pharmaceutical manufacturer Alpharma Inc.has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug Kadian, the Justice Department announced. The settlement resolves...
|
|
|
Ranbaxy Announces Settlement of Actos (Pioglitazone Hydrochloride) Patent Litigation
JACKSONVILLE, Fla., March 15 /PRNewswire/ -- Ranbaxy Laboratories Limited, along with its wholly owned subsidiary Ranbaxy Pharmaceuticals Inc.(collectively, 'Ranbaxy'), announced today that they have reached an agreement with Takeda Pharmaceutical Company...
|
|
|
$9.5M Facebook privacy settlement approved
A federal judge has approved a $9.5 million settlement in a privacy lawsuit against Facebook Inc., which will put about $6 million into a non-profit foundation to promote online privacy.District Court Judge Richard Seeborg in San Jose approved the plan...
|
|
|
Sen. Kohl Vows to Keep Fighting for Ban on Generic Settlements
Drugmakers probably wont have to worry about a ban on pay-for-delay patent dispute settlements in the healthcare reform measure moving through Congress, but Sen.Kohl Vows to Keep Fighting for Ban on Generic Settlements.
|
|
|
Alpharma to Pay $42.5 Million in False Claims Settlement
Drugmakers Alpharma and Alpharma Pharmaceuticals have agreed to pay $42.Alpharma to Pay $42.5 Million in False Claims Settlement.
|
|
|
Caliper Settles Outstanding Litigation with Shimadzu
HOPKINTON, Mass., March 15 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc.( NASDAQ:CALP) , a leading provider of tools and services for drug discovery and life sciences research, today announces that it has entered into a settlement agreement...
|
|
|
Defrauding Medicare: Hamilton, N.J. hospital to pay $6.35M for settling allegations
Robert Wood Johnson University Hospital Hamilton, a New Jersey-based hospital, has agreed to pay $6.35 million to settle allegations that the hospital defrauded Medicare, the Justice Department announced today.Two lawsuits filed against the Hamilton, N.J.,...
|
|
|
Drug Makers Shout 'Huzzah!' as 'Pay for Delay' Ban Cut From Health Bill
Generic drug makers are applauding the latest change to the health care bill -- eliminating the ban on patent settlements.The measure, which was backed by the Federal Trade Commission, would in most cases have barred so-called 'pay for delay' ...
|
|
|
Alpharma to pay $42.5 million plus interest to US Department of Justice to settle Kadian product lawsuit
King Pharmaceuticals, Inc.announced that its subsidiaries, Alpharma Inc. and Alpharma Pharmaceuticals LLC (Alpharma), have finalized a civil settlement with the United States Department of Justice and the Office of the United States Attorney for the...
|
|
|
New Health Reform Bill Drops Ban on 'Pay-for-Delay' Deals
ARLINGTON, Va.- The health care reform bill scheduled to be voted on Sunday by the House may not completely be what the pharmaceutical industry was seeking, said David Brennan, CEO of AstraZeneca plc. "But it will be a giant step," he said at the annual...
|
|
|
New Health Reform Bill Drops Ban on 'Pay-for-Delay' Deals
ARLINGTON, Va.- The health care reform bill scheduled to be voted on Sunday by the House may not completely be what the pharmaceutical industry was seeking, said David Brennan, CEO of AstraZeneca plc. 'But it will be a giant step,' he said at the annual...
|
|
|
EU, Argentina End Seven-Year WTO BiotechRow
The WTO dispute launched by Argentina against the EU over its biotechnology legislation in May 2003 ended Thursday with the two countries coming to an agreement on how to handle issues related to biotech trade in the future.The settlement establishes...
|
|
|
Bucking Horse Energy Inc. Announces Acquisition of Securities Through Settlement of Outstanding Debt
2:10 PM EST Bucking Horse Energy Inc.(the 'Company' and 'Bucking Horse') (TSX: BUC) announces that it has acquired through its wholly-owned subsidiary Gemini Energy Corp. ('Gemini') 600,000 common shares of XXL Energy Corp. ('XXL'). The acquisition of...
|
|
|
FDA restricts the sale, distribution and use of cigarettes and smokeless tobacco
A rule issued today by the Food and Drug Administration (FDA) underscores the historical progress made towards fighting the nation's number one cause of preventable death: tobacco-related disease.On June 22, 2009, President Obama signed into law the Family...
|
|
|
Sen. Kohl Vows to Keep Fighting for Ban on Generic-Brand Settlements
Drugmakers probably wont have to worry about a ban on pay-for-delay patent dispute settlements in the healthcare reform measure moving through Congress this Sen.Kohl Vows to Keep Fighting for Ban on Generic-Brand Settlements.
|
|
|
New Jersey Hospital to Pay $6.35 Million to Resolve Allegations of Inflating Charges to Obtain Higher Medicare
WASHINGTON - Robert Wood Johnson University Hospital Hamilton, a New Jersey-based hospital, has agreed to pay $6.35 million to settle allegations that the hospital defrauded Medicare, the Justice Department announced today.Two lawsuits filed against the...
|
|
|
AstraZeneca wins 1st trial over alleged drug harm
AstraZeneca PLC's blockbuster psychiatric drug Seroquel did not trigger diabetes in a Vietnam veteran, a jury ruled Thursday in the first trial out of thousands of cases alleging the powerful drug caused diabetes.The British drugmaker said a jury in...
|
|
|
Pay-for-delay ban dropped from reform bill
Healthcare reform just started to look better for pharma: That ban on pay-for-delay deals has been dropped from the legislation.The provision would have barred patent settlements in which generics firms agree to hold off on their copycat-drug plans in...
|
|
|
EU and Argentina settle WTO case on Genetically Modified Organisms
The European Union and Argentina have today signed in Buenos Aires a final settlement of the WTO dispute that Argentina brought against the EU in May 2003 regarding the application of its legislation on biotech products.The mutually agreed solution...
|
|
|
Indiana Joins Alpharma Settlement
Indiana's share of a national settlement with New Jersey-based Alpharma Inc.is nearly $300,000. Attorney General Greg Zoeller says the company agreed to pay several states and the federal government a combined $42.5 million, plus interest, to settle...
|
|
|
Alpharma To Pay $42.5M To Resolve False Claims Act Allegations In Connection With Promotion Of Drug Kadian
Washington, /PRNewswire-USNewswire/ -- American pharmaceutical manufacturer Alpharma Inc.has agreed to pay $42.5M to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced...
|
|
|
Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian
WASHINGTON, March 16 /PRNewswire-USNewswire/ -- American pharmaceutical manufacturer Alpharma Inc.has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice...
|
|
|
AstraZeneca Wins 1st Trial Over Alleged Drug Harm
TRENTON, N.J.(AP) -- AstraZeneca PLC's blockbuster psychiatric drug Seroquel did not trigger diabetes in a Vietnam veteran, a jury ruled Thursday in the first trial out of thousands of cases alleging the powerful drug caused diabetes. The British drugmaker...
|
